Welcome to our dedicated page for Aehr Test Sys SEC filings (Ticker: AEHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Aehr Test Systems filings document material events, operating results, capital actions and governance matters for a semiconductor test and burn-in equipment company. Recent Form 8-K disclosures include quarterly financial-result releases covering revenue, bookings, backlog, cash position and GAAP and non-GAAP earnings measures.
The filing record also includes capital-structure disclosures tied to an at-the-market common stock offering under a Form S-3 registration statement, along with proxy and annual meeting materials. Those governance filings address director elections, shareholder voting results, amendments to the company’s equity incentive and employee stock purchase plans, auditor ratification and executive-compensation matters.
Alistair Sporck reported sales of Common Stock of Charles Schwab Corp. under a Rule 144 notice. The filing lists three transactions: 3,000 shares sold on 02/09/2026 for $82,716, 2,000 shares sold on 04/10/2026 for $134,730, and 2,000 shares sold on 04/16/2026 for $163,760.
The form also lists shares associated with an Employee Stock Purchase Plan dated 04/01/2024 (1,181 shares) and 10/01/2024 (819 shares) via payroll deductions.
Aehr Test Systems director Geoffrey Scott reported net open-market sales of 60,000 shares of Common Stock. Entities associated with him sold 50,000 shares at $95.00 per share through his spouse and 10,000 shares at $91.00 per share through a trust.
Following these transactions, he reports 52,864 shares held directly, 50,000 shares held indirectly by his spouse, and 50,686 shares held indirectly by a trust. The reported amounts include shares subject to unvested restricted stock units.
Aehr Test Systems executive Vernon Rogers sold 5,000 shares of Common Stock in an open-market transaction at $90.00 per share. After the sale, he directly holds 147,716 shares, which the disclosure states include shares subject to unvested restricted stock units. The transaction represents a small portion of his reported holdings and reflects a routine sale by the company’s Executive Vice President of Sales & Marketing.
Aehr Test Systems director Rhea J. Posedel reported an open-market sale of 8,787 shares of Common Stock at an average price of $96.0233 per share. The transaction occurred on April 21, 2026 and was recorded as a non-derivative sale.
Following the sale, she directly holds 62,376 Aehr shares. A separate indirect holding entry shows 396,979 shares held by a trust, and a footnote explains that this amount includes shares subject to unvested restricted stock units.
Aehr Test Systems executive vice president of sales and marketing Vernon Rogers reported an open-market sale of 6,486 shares of Common Stock at $94.0904 per share on April 21, 2026.
After this transaction, he directly holds 152,716 shares, and this figure includes shares underlying unvested restricted stock units. The sale amounts to roughly a small single-digit percentage of his reported holdings.
AEHR Manufacturing reported proposed insider sales of common stock via Form 144. The filing shows Vernon Rogers listed proposed dispositions of 2,431 shares on 04/20/2026, 5,000 shares on 04/16/2026, and 10,888 shares on 04/10/2026, with dollar values provided for each transaction. The shares are identified as common stock and one entry references an ESOP as issuer-related.
AEHR Technologies reported multiple Form 144 sales of common stock by an insider. The filing lists transactions dated 02/13/2026 through 04/20/2026, showing individual sales of 13,998, 30,000, 15,000, 7,500, and 7,500 shares. The entries include gross proceeds for each sale.
Aehr Test Systems reported proposed resale transactions on Form 144 by Geoffrey Scott. The filing lists a sale of 40,000 shares dated 04/09/2026 for $2,718,978.35 and a sale of 10,000 shares dated 04/21/2026 for $910,000. The transactions are identified as common stock sales for cash.
Alberto Salamone submitted a Form 144 notice for the proposed sale of 15,000 shares of Common Stock. The filing shows a trade date 04/20/2026 and a reported value of $1,343,589.55. The securities were issued as restricted stock vesting on 08/01/2024, tied to compensation.
AEHR Test Systems filing on Form 144 reports an insider disposition of 40,000 shares of Common Stock on 04/09/2026, with proceeds listed as $2,718,978.35. The filing references a prior private placement of 100,000 shares dated 11/24/2014 and shows 31,453,254 shares on record with a date of 04/21/2026.